ABBV vs COR
By Alex · Tickerpine
AbbVie Inc. vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | COR |
|---|---|---|
| Price | $248.76 | $314.17 |
| Market cap | $439.59B | $59.95B |
| P/E ratio | 70.5 | 24.8 |
| ROE | — | 96.87% |
| Profit margin | 9.80% | 0.79% |
| Revenue growth | 10.20% | 5.10% |
| Dividend yield | 2.77% | 0.72% |
| Beta | 0.28 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs COR in plain English
- ABBV is the bigger company — about 7.3× the market cap of COR.
- COR is cheaper on earnings (P/E 24.8 vs 70.5).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV has the higher dividend yield (2.77% vs 0.72%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.